Halal gelatin extracted from goatskin could be used as a new excipient in pharmaceutical dosage forms. This study was to determine the potency of gelatin extracted from goatskin as a binder on paracetamol tablets using wet granulation process with 2, 3 and 4% concentration ranges. As a comparison, tablets were formulated using bovine gelatin at the same concentration level. The results showed that weight variation, thickness uniformity and hardness value have met the requirements. Here, the paracetamol tablets using goatskin gelatin as a binder had better friability value, faster disintegration time and easier dissolution than the comparison (p < 0.05). Comparative test result showed increasing the concentration of gelatine caused the hardness value to go up, the disintegration time to take longer, and the tablet friability value to decrease (p < 0.05). The best tablets were produced with the 3% concentration of goatskin gelatine with the following evaluation results: the hardness value of 15.07 ± 0.67 Kp, the disintegration time of 3.71 ± 1.00 minutes and the friability value of 0.62% ± 0.89 respectively. The concentration of paracetamol in the 30th-minute dissolution test was equal to 99.78 ± 0.94%. The goatskin gelatin was very promising as a good binder using the wet granulation process.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.